

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | leukocyte aggregation (GO:0070486) | 7.58140689 |
| 2 | regulation of B cell receptor signaling pathway (GO:0050855) | 6.81252066 |
| 3 | cellular extravasation (GO:0045123) | 6.22297366 |
| 4 | negative regulation of cell killing (GO:0031342) | 5.95204812 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.95204812 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.59799327 |
| 7 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.28174912 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 4.97025192 |
| 9 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.82916266 |
| 10 | tolerance induction (GO:0002507) | 4.73692103 |
| 11 | positive regulation of mast cell activation (GO:0033005) | 4.63164640 |
| 12 | cellular response to interleukin-15 (GO:0071350) | 4.57996166 |
| 13 | macrophage differentiation (GO:0030225) | 4.56362434 |
| 14 | response to interleukin-15 (GO:0070672) | 4.50198336 |
| 15 | negative T cell selection (GO:0043383) | 4.49267036 |
| 16 | neutrophil activation (GO:0042119) | 4.47815033 |
| 17 | response to peptidoglycan (GO:0032494) | 4.47645527 |
| 18 | negative thymic T cell selection (GO:0045060) | 4.47424718 |
| 19 | neutrophil mediated immunity (GO:0002446) | 4.40366017 |
| 20 | respiratory burst (GO:0045730) | 4.37513488 |
| 21 | positive thymic T cell selection (GO:0045059) | 4.28372377 |
| 22 | detection of molecule of bacterial origin (GO:0032490) | 4.22607429 |
| 23 | positive regulation by symbiont of host defense response (GO:0052509) | 4.21082590 |
| 24 | modulation by symbiont of host defense response (GO:0052031) | 4.21082590 |
| 25 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.21082590 |
| 26 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.21082590 |
| 27 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.21082590 |
| 28 | modulation by symbiont of host immune response (GO:0052553) | 4.21082590 |
| 29 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.20667838 |
| 30 | detection of external biotic stimulus (GO:0098581) | 4.18762916 |
| 31 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.17092695 |
| 32 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.17092695 |
| 33 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.15396492 |
| 34 | response to host immune response (GO:0052572) | 4.12585865 |
| 35 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.12585865 |
| 36 | regulation of gamma-delta T cell activation (GO:0046643) | 4.11080005 |
| 37 | granulocyte activation (GO:0036230) | 4.10950635 |
| 38 | neutrophil chemotaxis (GO:0030593) | 4.04891081 |
| 39 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.94960174 |
| 40 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.94873466 |
| 41 | microglial cell activation (GO:0001774) | 3.94174409 |
| 42 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.94110288 |
| 43 | neutrophil migration (GO:1990266) | 3.93436809 |
| 44 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.91071934 |
| 45 | response to host (GO:0075136) | 3.91071934 |
| 46 | response to host defenses (GO:0052200) | 3.91071934 |
| 47 | leukocyte cell-cell adhesion (GO:0007159) | 3.88325027 |
| 48 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.88116505 |
| 49 | activated T cell proliferation (GO:0050798) | 3.78274131 |
| 50 | thymic T cell selection (GO:0045061) | 3.78167922 |
| 51 | detection of biotic stimulus (GO:0009595) | 3.77305080 |
| 52 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.75499363 |
| 53 | defense response to fungus (GO:0050832) | 3.75327258 |
| 54 | regulation of B cell differentiation (GO:0045577) | 3.73569499 |
| 55 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.72877871 |
| 56 | macrophage activation (GO:0042116) | 3.71224175 |
| 57 | granulocyte chemotaxis (GO:0071621) | 3.68811755 |
| 58 | negative regulation of T cell mediated immunity (GO:0002710) | 3.67238360 |
| 59 | positive T cell selection (GO:0043368) | 3.67088737 |
| 60 | negative regulation of phagocytosis (GO:0050765) | 3.66064706 |
| 61 | regulation of T cell tolerance induction (GO:0002664) | 3.62821048 |
| 62 | interferon-gamma production (GO:0032609) | 3.58333111 |
| 63 | negative regulation of interleukin-12 production (GO:0032695) | 3.56917990 |
| 64 | granulocyte migration (GO:0097530) | 3.56404626 |
| 65 | immunoglobulin mediated immune response (GO:0016064) | 3.56065632 |
| 66 | T cell migration (GO:0072678) | 3.54069772 |
| 67 | regulation of mast cell activation (GO:0033003) | 3.53495614 |
| 68 | T cell selection (GO:0045058) | 3.53272602 |
| 69 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.49777064 |
| 70 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.47109144 |
| 71 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.45081859 |
| 72 | response to muramyl dipeptide (GO:0032495) | 3.41469536 |
| 73 | myeloid leukocyte mediated immunity (GO:0002444) | 3.41258930 |
| 74 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.40162897 |
| 75 | positive regulation of tolerance induction (GO:0002645) | 3.37953096 |
| 76 | positive regulation of B cell differentiation (GO:0045579) | 3.37535004 |
| 77 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.36700260 |
| 78 | response to fungus (GO:0009620) | 3.35398580 |
| 79 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.31224563 |
| 80 | positive regulation of mast cell degranulation (GO:0043306) | 3.31224563 |
| 81 | T cell costimulation (GO:0031295) | 3.29506233 |
| 82 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.28222701 |
| 83 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.26241969 |
| 84 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.25784613 |
| 85 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.25738332 |
| 86 | detection of other organism (GO:0098543) | 3.25352231 |
| 87 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.24849453 |
| 88 | B cell receptor signaling pathway (GO:0050853) | 3.24065472 |
| 89 | lymphocyte costimulation (GO:0031294) | 3.23008709 |
| 90 | leukocyte degranulation (GO:0043299) | 3.22890104 |
| 91 | dendritic cell migration (GO:0036336) | 3.21879027 |
| 92 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.17671198 |
| 93 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.17046235 |
| 94 | regulation of receptor binding (GO:1900120) | 3.16739265 |
| 95 | cellular defense response (GO:0006968) | 3.16687150 |
| 96 | dendritic cell chemotaxis (GO:0002407) | 3.16589271 |
| 97 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.16582240 |
| 98 | T cell receptor signaling pathway (GO:0050852) | 3.16500416 |
| 99 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.15677379 |
| 100 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.13853141 |
| 101 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.13721379 |
| 102 | regulation of tolerance induction (GO:0002643) | 3.11831913 |
| 103 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.11760471 |
| 104 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.11528902 |
| 105 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.10981577 |
| 106 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.09041752 |
| 107 | detection of bacterium (GO:0016045) | 3.08420985 |
| 108 | B cell mediated immunity (GO:0019724) | 3.08276509 |
| 109 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.05680669 |
| 110 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.05043721 |
| 111 | endodermal cell differentiation (GO:0035987) | 3.00917124 |
| 112 | oxygen transport (GO:0015671) | 3.00179562 |
| 113 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.00073297 |
| 114 | defense response to protozoan (GO:0042832) | 2.99692597 |
| 115 | myeloid cell activation involved in immune response (GO:0002275) | 2.98885088 |
| 116 | regulation of regulatory T cell differentiation (GO:0045589) | 2.98706219 |
| 117 | regulation of leukocyte degranulation (GO:0043300) | 2.98557305 |
| 118 | myeloid leukocyte activation (GO:0002274) | 2.97164581 |
| 119 | negative regulation of type 2 immune response (GO:0002829) | 2.93292272 |
| 120 | macrophage activation involved in immune response (GO:0002281) | 2.92453550 |
| 121 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.90774152 |
| 122 | positive regulation of interferon-alpha production (GO:0032727) | 2.89219812 |
| 123 | negative regulation of interleukin-6 production (GO:0032715) | 2.86383862 |
| 124 | regulation of mast cell degranulation (GO:0043304) | 2.86316845 |
| 125 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.85912925 |
| 126 | type I interferon signaling pathway (GO:0060337) | 2.85867566 |
| 127 | cellular response to type I interferon (GO:0071357) | 2.85867566 |
| 128 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.85642936 |
| 129 | response to type I interferon (GO:0034340) | 2.85432025 |
| 130 | regulation of regulated secretory pathway (GO:1903305) | 2.84958960 |
| 131 | regulation of interferon-alpha production (GO:0032647) | 2.84747070 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.53137457 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.37348863 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.82768728 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.10019081 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 4.06099358 |
| 6 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.62122237 |
| 7 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.59529136 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.45125406 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.44569581 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.14763401 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.09581497 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.02635108 |
| 13 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.00346801 |
| 14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.00096025 |
| 15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.88886929 |
| 16 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.86389927 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.83092559 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.79790029 |
| 19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.72897669 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.65609692 |
| 21 | * MYB_26560356_Chip-Seq_TH2_Human | 2.65535110 |
| 22 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.64002550 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 2.57795233 |
| 24 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.50714036 |
| 25 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.40016852 |
| 26 | UTX_26944678_Chip-Seq_JUKART_Human | 2.38841977 |
| 27 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.29717558 |
| 28 | MYB_26560356_Chip-Seq_TH1_Human | 2.21904466 |
| 29 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.20196445 |
| 30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.16075130 |
| 31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.14939287 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.14444903 |
| 33 | SPI1_23127762_ChIP-Seq_K562_Human | 2.10492915 |
| 34 | MYC_22102868_ChIP-Seq_BL_Human | 2.05607626 |
| 35 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.04846996 |
| 36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.98593097 |
| 37 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.94016406 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93882579 |
| 39 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.91610400 |
| 40 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.88190385 |
| 41 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.86508348 |
| 42 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.80585751 |
| 43 | MAF_26560356_Chip-Seq_TH2_Human | 1.76193928 |
| 44 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.74708302 |
| 45 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.74155720 |
| 46 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.71903898 |
| 47 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69051723 |
| 48 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.64651176 |
| 49 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.61048250 |
| 50 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.60975134 |
| 51 | GATA1_22025678_ChIP-Seq_K562_Human | 1.60825673 |
| 52 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.59983011 |
| 53 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.52858043 |
| 54 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.52544418 |
| 55 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.50774234 |
| 56 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.49572317 |
| 57 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.48280546 |
| 58 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.44483508 |
| 59 | GATA3_26560356_Chip-Seq_TH2_Human | 1.44195576 |
| 60 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.43540284 |
| 61 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.37351185 |
| 62 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.36260246 |
| 63 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.33492238 |
| 64 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31863359 |
| 65 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27675614 |
| 66 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26175195 |
| 67 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.22653077 |
| 68 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22440164 |
| 69 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21627168 |
| 70 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21111624 |
| 71 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18084168 |
| 72 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.16592787 |
| 73 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.14137039 |
| 74 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.13646821 |
| 75 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.12956408 |
| 76 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09193235 |
| 77 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08248821 |
| 78 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.08033683 |
| 79 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07734596 |
| 80 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.07039336 |
| 81 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.05749324 |
| 82 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.04932728 |
| 83 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.04432217 |
| 84 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.04362672 |
| 85 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.03538984 |
| 86 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03220891 |
| 87 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.02157138 |
| 88 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01679251 |
| 89 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.92667430 |
| 90 | GATA2_19941826_ChIP-Seq_K562_Human | 0.92195835 |
| 91 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.91440971 |
| 92 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87202095 |
| 93 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86192736 |
| 94 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.85660616 |
| 95 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.84646090 |
| 96 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.82546163 |
| 97 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.80695954 |
| 98 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.79320101 |
| 99 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.79050804 |
| 100 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.78065292 |
| 101 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.75933316 |
| 102 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.75016759 |
| 103 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.74738695 |
| 104 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74073751 |
| 105 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.74052203 |
| 106 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.71668440 |
| 107 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.68801419 |
| 108 | P300_27268052_Chip-Seq_Bcells_Human | 0.68691661 |
| 109 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.65371776 |
| 110 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.65310399 |
| 111 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.64388346 |
| 112 | GATA1_19941826_ChIP-Seq_K562_Human | 0.64264229 |
| 113 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.64103893 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 4.55877823 |
| 2 | MP0009278_abnormal_bone_marrow | 3.40892597 |
| 3 | MP0005671_abnormal_response_to | 3.40719007 |
| 4 | MP0003303_peritoneal_inflammation | 3.40258179 |
| 5 | MP0009785_altered_susceptibility_to | 3.30220795 |
| 6 | MP0001835_abnormal_antigen_presentation | 3.16110160 |
| 7 | MP0002837_dystrophic_cardiac_calcinosis | 2.92967548 |
| 8 | MP0002419_abnormal_innate_immunity | 2.91165514 |
| 9 | MP0001853_heart_inflammation | 2.86939664 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.79222894 |
| 11 | MP0001800_abnormal_humoral_immune | 2.70957709 |
| 12 | MP0000685_abnormal_immune_system | 2.70532443 |
| 13 | MP0005025_abnormal_response_to | 2.62829689 |
| 14 | MP0003724_increased_susceptibility_to | 2.60675738 |
| 15 | MP0002933_joint_inflammation | 2.56239027 |
| 16 | MP0004510_myositis | 2.51889958 |
| 17 | MP0001790_abnormal_immune_system | 2.51539130 |
| 18 | MP0005387_immune_system_phenotype | 2.51539130 |
| 19 | MP0005167_abnormal_blood-brain_barrier | 2.48148647 |
| 20 | MP0002452_abnormal_antigen_presenting | 2.48126317 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 2.48049781 |
| 22 | MP0002420_abnormal_adaptive_immunity | 2.47631724 |
| 23 | MP0001819_abnormal_immune_cell | 2.46313334 |
| 24 | MP0003763_abnormal_thymus_physiology | 2.44115110 |
| 25 | MP0002723_abnormal_immune_serum | 2.41018274 |
| 26 | MP0002405_respiratory_system_inflammati | 2.39391225 |
| 27 | MP0001533_abnormal_skeleton_physiology | 2.24803605 |
| 28 | MP0000858_altered_metastatic_potential | 2.09342841 |
| 29 | MP0008260_abnormal_autophagy | 2.07997589 |
| 30 | MP0006082_CNS_inflammation | 2.06279950 |
| 31 | MP0002396_abnormal_hematopoietic_system | 2.03067816 |
| 32 | MP0003300_gastrointestinal_ulcer | 2.01072223 |
| 33 | MP0002398_abnormal_bone_marrow | 1.96618577 |
| 34 | MP0000343_altered_response_to | 1.94506266 |
| 35 | MP0005397_hematopoietic_system_phenotyp | 1.93005237 |
| 36 | MP0001545_abnormal_hematopoietic_system | 1.93005237 |
| 37 | MP0000716_abnormal_immune_system | 1.90822705 |
| 38 | MP0002166_altered_tumor_susceptibility | 1.89387542 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.85414319 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.85031517 |
| 41 | MP0005464_abnormal_platelet_physiology | 1.72202796 |
| 42 | MP0009764_decreased_sensitivity_to | 1.70114738 |
| 43 | MP0003448_altered_tumor_morphology | 1.68856198 |
| 44 | MP0009333_abnormal_splenocyte_physiolog | 1.68492410 |
| 45 | MP0000689_abnormal_spleen_morphology | 1.67629047 |
| 46 | MP0003279_aneurysm | 1.66031609 |
| 47 | MP0004947_skin_inflammation | 1.61924439 |
| 48 | MP0004808_abnormal_hematopoietic_stem | 1.60904259 |
| 49 | MP0001873_stomach_inflammation | 1.57642844 |
| 50 | MP0002722_abnormal_immune_system | 1.57532148 |
| 51 | MP0003075_altered_response_to | 1.57320850 |
| 52 | MP0003828_pulmonary_edema | 1.52362689 |
| 53 | MP0002429_abnormal_blood_cell | 1.51863712 |
| 54 | MP0000569_abnormal_digit_pigmentation | 1.51804099 |
| 55 | MP0002006_tumorigenesis | 1.50496643 |
| 56 | MP0003866_abnormal_defecation | 1.44825258 |
| 57 | MP0003191_abnormal_cellular_cholesterol | 1.44760138 |
| 58 | MP0004883_abnormal_blood_vessel | 1.43851992 |
| 59 | MP0003690_abnormal_glial_cell | 1.39343700 |
| 60 | MP0000703_abnormal_thymus_morphology | 1.36298621 |
| 61 | MP0001851_eye_inflammation | 1.35575259 |
| 62 | MP0008469_abnormal_protein_level | 1.34329715 |
| 63 | MP0005023_abnormal_wound_healing | 1.31710735 |
| 64 | MP0002277_abnormal_respiratory_mucosa | 1.30131329 |
| 65 | MP0005166_decreased_susceptibility_to | 1.28262822 |
| 66 | MP0003183_abnormal_peptide_metabolism | 1.24133232 |
| 67 | MP0005058_abnormal_lysosome_morphology | 1.23575200 |
| 68 | MP0003453_abnormal_keratinocyte_physiol | 1.23453012 |
| 69 | MP0003806_abnormal_nucleotide_metabolis | 1.19948585 |
| 70 | MP0000465_gastrointestinal_hemorrhage | 1.17873228 |
| 71 | MP0005310_abnormal_salivary_gland | 1.14700389 |
| 72 | MP0000015_abnormal_ear_pigmentation | 1.11632865 |
| 73 | MP0005390_skeleton_phenotype | 1.05868680 |
| 74 | MP0008004_abnormal_stomach_pH | 1.04391451 |
| 75 | MP0003656_abnormal_erythrocyte_physiolo | 1.00524631 |
| 76 | MP0004381_abnormal_hair_follicle | 0.97184879 |
| 77 | MP0003172_abnormal_lysosome_physiology | 0.96109251 |
| 78 | MP0009840_abnormal_foam_cell | 0.95897402 |
| 79 | MP0002998_abnormal_bone_remodeling | 0.95713529 |
| 80 | MP0005076_abnormal_cell_differentiation | 0.92756808 |
| 81 | MP0005164_abnormal_response_to | 0.89522468 |
| 82 | MP0009763_increased_sensitivity_to | 0.84743546 |
| 83 | MP0008961_abnormal_basal_metabolism | 0.80608509 |
| 84 | MP0003638_abnormal_response/metabolism_ | 0.78872395 |
| 85 | MP0005075_abnormal_melanosome_morpholog | 0.78089156 |
| 86 | MP0006054_spinal_hemorrhage | 0.78026530 |
| 87 | MP0003795_abnormal_bone_structure | 0.75345597 |
| 88 | MP0009765_abnormal_xenobiotic_induced | 0.74558822 |
| 89 | MP0005451_abnormal_body_composition | 0.73977757 |
| 90 | MP0000920_abnormal_myelination | 0.73767764 |
| 91 | MP0002132_abnormal_respiratory_system | 0.73185266 |
| 92 | MP0002009_preneoplasia | 0.72613348 |
| 93 | MP0004130_abnormal_muscle_cell | 0.71820565 |
| 94 | MP0001663_abnormal_digestive_system | 0.70214818 |
| 95 | MP0003566_abnormal_cell_adhesion | 0.69480489 |
| 96 | MP0000249_abnormal_blood_vessel | 0.68489670 |
| 97 | MP0005174_abnormal_tail_pigmentation | 0.67404160 |
| 98 | MP0002019_abnormal_tumor_incidence | 0.66424604 |
| 99 | MP0001764_abnormal_homeostasis | 0.65939002 |
| 100 | MP0002138_abnormal_hepatobiliary_system | 0.63437701 |
| 101 | MP0000604_amyloidosis | 0.63319376 |
| 102 | MP0008874_decreased_physiological_sensi | 0.61903026 |
| 103 | MP0000490_abnormal_crypts_of | 0.60219236 |
| 104 | MP0002254_reproductive_system_inflammat | 0.60098071 |
| 105 | MP0003329_amyloid_beta_deposits | 0.59662726 |
| 106 | MP0002332_abnormal_exercise_endurance | 0.58452024 |
| 107 | MP0003221_abnormal_cardiomyocyte_apopto | 0.55004108 |
| 108 | MP0001216_abnormal_epidermal_layer | 0.54684211 |
| 109 | MP0001191_abnormal_skin_condition | 0.51919237 |
| 110 | MP0009115_abnormal_fat_cell | 0.48908731 |
| 111 | MP0003091_abnormal_cell_migration | 0.47412771 |
| 112 | MP0005388_respiratory_system_phenotype | 0.47078443 |
| 113 | MP0002133_abnormal_respiratory_system | 0.47078443 |
| 114 | MP0003045_fibrosis | 0.46548366 |
| 115 | MP0006072_abnormal_retinal_apoptosis | 0.41972060 |
| 116 | MP0000609_abnormal_liver_physiology | 0.41658633 |
| 117 | MP0002928_abnormal_bile_duct | 0.40615292 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.47173408 |
| 2 | Eczematoid dermatitis (HP:0000976) | 7.37215585 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.17230375 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.93411450 |
| 5 | Stomatitis (HP:0010280) | 5.62152379 |
| 6 | Recurrent fungal infections (HP:0002841) | 4.85099170 |
| 7 | Myositis (HP:0100614) | 4.55402067 |
| 8 | Abnormality of macrophages (HP:0004311) | 4.46849317 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 4.44926371 |
| 10 | Recurrent skin infections (HP:0001581) | 4.38078141 |
| 11 | Chronic obstructive pulmonary disease (HP:0006510) | 4.35018702 |
| 12 | Obstructive lung disease (HP:0006536) | 4.35018702 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.25006652 |
| 14 | IgM deficiency (HP:0002850) | 4.20119897 |
| 15 | Gingivitis (HP:0000230) | 4.09116298 |
| 16 | Abnormality of glycolipid metabolism (HP:0010969) | 4.02456780 |
| 17 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.02456780 |
| 18 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.02456780 |
| 19 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.00475045 |
| 20 | Recurrent cutaneous fungal infections (HP:0011370) | 4.00475045 |
| 21 | Orchitis (HP:0100796) | 3.87071505 |
| 22 | Pustule (HP:0200039) | 3.65280518 |
| 23 | Recurrent viral infections (HP:0004429) | 3.45744919 |
| 24 | Gastrointestinal infarctions (HP:0005244) | 3.45391319 |
| 25 | Retrobulbar optic neuritis (HP:0100654) | 3.42837791 |
| 26 | Optic neuritis (HP:0100653) | 3.42837791 |
| 27 | Inflammation of the large intestine (HP:0002037) | 3.37664677 |
| 28 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.37063810 |
| 29 | Meningitis (HP:0001287) | 3.33818081 |
| 30 | Abnormality of T cell number (HP:0011839) | 3.29965462 |
| 31 | T lymphocytopenia (HP:0005403) | 3.26853490 |
| 32 | Spontaneous hematomas (HP:0007420) | 3.24191327 |
| 33 | Urticaria (HP:0001025) | 3.18417908 |
| 34 | Periodontitis (HP:0000704) | 3.16292850 |
| 35 | Colitis (HP:0002583) | 3.15776949 |
| 36 | Gastrointestinal inflammation (HP:0004386) | 3.14088721 |
| 37 | Chronic otitis media (HP:0000389) | 3.07939316 |
| 38 | Chronic diarrhea (HP:0002028) | 2.93198381 |
| 39 | Abnormality of T cells (HP:0002843) | 2.92119782 |
| 40 | Vasculitis (HP:0002633) | 2.89942795 |
| 41 | Cellulitis (HP:0100658) | 2.87025496 |
| 42 | Short femoral neck (HP:0100864) | 2.82321315 |
| 43 | Hepatosplenomegaly (HP:0001433) | 2.82077415 |
| 44 | Disinhibition (HP:0000734) | 2.80221469 |
| 45 | Amyloidosis (HP:0011034) | 2.79331032 |
| 46 | Loss of speech (HP:0002371) | 2.75154509 |
| 47 | Petechiae (HP:0000967) | 2.74808760 |
| 48 | Leukocytosis (HP:0001974) | 2.73458617 |
| 49 | Vacuolated lymphocytes (HP:0001922) | 2.72319204 |
| 50 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.67796087 |
| 51 | Metaphyseal irregularity (HP:0003025) | 2.66340252 |
| 52 | Keratoconjunctivitis sicca (HP:0001097) | 2.66147771 |
| 53 | Hematochezia (HP:0002573) | 2.63884680 |
| 54 | Hemoptysis (HP:0002105) | 2.63228864 |
| 55 | Lymphopenia (HP:0001888) | 2.61333642 |
| 56 | Nasal polyposis (HP:0100582) | 2.59447362 |
| 57 | Pulmonary infiltrates (HP:0002113) | 2.59194583 |
| 58 | Arterial thrombosis (HP:0004420) | 2.58876449 |
| 59 | Interstitial pulmonary disease (HP:0006530) | 2.57883269 |
| 60 | Thickened calvaria (HP:0002684) | 2.57679049 |
| 61 | Episodic fever (HP:0001954) | 2.54825263 |
| 62 | Joint swelling (HP:0001386) | 2.54701685 |
| 63 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.53776399 |
| 64 | Panhypogammaglobulinemia (HP:0003139) | 2.51713807 |
| 65 | Anorexia (HP:0002039) | 2.48505259 |
| 66 | Recurrent bronchitis (HP:0002837) | 2.45990443 |
| 67 | Eosinophilia (HP:0001880) | 2.45307487 |
| 68 | Cheilitis (HP:0100825) | 2.44642279 |
| 69 | Encephalitis (HP:0002383) | 2.44569998 |
| 70 | Abnormality of T cell physiology (HP:0011840) | 2.43106406 |
| 71 | Purpura (HP:0000979) | 2.43098726 |
| 72 | Keratoconjunctivitis (HP:0001096) | 2.39792184 |
| 73 | Recurrent sinusitis (HP:0011108) | 2.39224977 |
| 74 | Increased IgM level (HP:0003496) | 2.37642000 |
| 75 | Gangrene (HP:0100758) | 2.37625578 |
| 76 | Autoimmune hemolytic anemia (HP:0001890) | 2.34850038 |
| 77 | Severe combined immunodeficiency (HP:0004430) | 2.32627353 |
| 78 | Skin ulcer (HP:0200042) | 2.31730985 |
| 79 | Autoimmune thrombocytopenia (HP:0001973) | 2.31589811 |
| 80 | Polyneuropathy (HP:0001271) | 2.30644168 |
| 81 | Abnormality of the nasal mucosa (HP:0000433) | 2.30496342 |
| 82 | Abnormality of the fingertips (HP:0001211) | 2.24847297 |
| 83 | Combined immunodeficiency (HP:0005387) | 2.24694921 |
| 84 | Abnormal platelet volume (HP:0011876) | 2.24039739 |
| 85 | Granulocytopenia (HP:0001913) | 2.21939185 |
| 86 | Thyroiditis (HP:0100646) | 2.20631190 |
| 87 | Abnormality of eosinophils (HP:0001879) | 2.19794725 |
| 88 | IgA deficiency (HP:0002720) | 2.19642318 |
| 89 | Abnormality of the pleura (HP:0002103) | 2.19051835 |
| 90 | Pulmonary embolism (HP:0002204) | 2.17382543 |
| 91 | Systemic lupus erythematosus (HP:0002725) | 2.16555411 |
| 92 | Epistaxis (HP:0000421) | 2.16327121 |
| 93 | Recurrent pneumonia (HP:0006532) | 2.16154698 |
| 94 | Increased serum ferritin (HP:0003281) | 2.13527296 |
| 95 | Gingival bleeding (HP:0000225) | 2.12111845 |
| 96 | Aplasia/hypoplasia of the femur (HP:0005613) | 2.10670850 |
| 97 | Osteomyelitis (HP:0002754) | 2.08925297 |
| 98 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.08390902 |
| 99 | Glomerulopathy (HP:0100820) | 2.07269189 |
| 100 | Increased IgE level (HP:0003212) | 2.07089073 |
| 101 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.05926647 |
| 102 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.05926647 |
| 103 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.05926647 |
| 104 | Chest pain (HP:0100749) | 2.05698206 |
| 105 | Prolonged bleeding time (HP:0003010) | 2.05317419 |
| 106 | Dysostosis multiplex (HP:0000943) | 2.04929502 |
| 107 | Increased cerebral lipofuscin (HP:0011813) | 2.02602516 |
| 108 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.02433538 |
| 109 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.01241535 |
| 110 | Vertigo (HP:0002321) | 1.99779499 |
| 111 | Papilledema (HP:0001085) | 1.98547521 |
| 112 | Verrucae (HP:0200043) | 1.98173402 |
| 113 | Papilloma (HP:0012740) | 1.98173402 |
| 114 | Mutism (HP:0002300) | 1.97148363 |
| 115 | Hypergammaglobulinemia (HP:0010702) | 1.96514705 |
| 116 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.96090932 |
| 117 | Hypochromic anemia (HP:0001931) | 1.94637804 |
| 118 | IgG deficiency (HP:0004315) | 1.92959638 |
| 119 | Sepsis (HP:0100806) | 1.92530029 |
| 120 | Amaurosis fugax (HP:0100576) | 1.92122439 |
| 121 | Recurrent lower respiratory tract infections (HP:0002783) | 1.89792143 |
| 122 | Peritonitis (HP:0002586) | 1.89679285 |
| 123 | Hypochromic microcytic anemia (HP:0004840) | 1.89502769 |
| 124 | Mucopolysacchariduria (HP:0008155) | 1.89463687 |
| 125 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.89463687 |
| 126 | Abnormality of iron homeostasis (HP:0011031) | 1.87941464 |
| 127 | Thoracic kyphosis (HP:0002942) | 1.86756947 |
| 128 | Spondylolisthesis (HP:0003302) | 1.85174112 |
| 129 | Increased density of long bones (HP:0006392) | 1.84632070 |
| 130 | Vertebral compression fractures (HP:0002953) | 1.82036973 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.07077089 |
| 2 | TXK | 3.61514584 |
| 3 | STK10 | 3.04228996 |
| 4 | ITK | 2.99564405 |
| 5 | IRAK4 | 2.98631602 |
| 6 | MAP2K3 | 2.84864703 |
| 7 | TYK2 | 2.67519754 |
| 8 | BLK | 2.66472282 |
| 9 | TEC | 2.57935323 |
| 10 | ZAP70 | 2.52129794 |
| 11 | TGFBR2 | 2.41644502 |
| 12 | BTK | 2.41339378 |
| 13 | CSK | 2.35982792 |
| 14 | CLK1 | 2.31520172 |
| 15 | PRPF4B | 2.28561797 |
| 16 | EPHB1 | 2.20765479 |
| 17 | HCK | 2.01339766 |
| 18 | IKBKE | 1.99159664 |
| 19 | ERN1 | 1.87862420 |
| 20 | JAK3 | 1.84502561 |
| 21 | TRPM7 | 1.84497903 |
| 22 | MAP3K3 | 1.83542705 |
| 23 | GRK6 | 1.80235692 |
| 24 | RIPK4 | 1.74675348 |
| 25 | FES | 1.73980166 |
| 26 | FGFR4 | 1.64941400 |
| 27 | TBK1 | 1.60071540 |
| 28 | JAK1 | 1.58184298 |
| 29 | FGR | 1.56777379 |
| 30 | RPS6KA4 | 1.55368403 |
| 31 | MAP3K14 | 1.49716143 |
| 32 | LCK | 1.39802751 |
| 33 | CAMKK2 | 1.38257504 |
| 34 | MAP3K12 | 1.30886914 |
| 35 | IRAK3 | 1.29193591 |
| 36 | TESK2 | 1.28674854 |
| 37 | MATK | 1.26819464 |
| 38 | LRRK2 | 1.26628034 |
| 39 | IKBKB | 1.22389578 |
| 40 | SYK | 1.20398313 |
| 41 | YES1 | 1.16062883 |
| 42 | KIT | 1.15980416 |
| 43 | FGFR3 | 1.13733313 |
| 44 | CDK12 | 1.12985983 |
| 45 | ERBB3 | 1.07484872 |
| 46 | BMPR2 | 1.04714048 |
| 47 | JAK2 | 1.01479708 |
| 48 | IRAK2 | 1.00227581 |
| 49 | IRAK1 | 0.98603000 |
| 50 | MARK3 | 0.96302097 |
| 51 | EEF2K | 0.95635757 |
| 52 | LYN | 0.95426012 |
| 53 | PRKCH | 0.93320609 |
| 54 | CSF1R | 0.92054015 |
| 55 | KDR | 0.91904995 |
| 56 | NLK | 0.91458926 |
| 57 | CDK19 | 0.91029484 |
| 58 | SIK3 | 0.90774886 |
| 59 | PDPK1 | 0.90103299 |
| 60 | TAOK1 | 0.88207502 |
| 61 | PKN2 | 0.87437966 |
| 62 | TRIB3 | 0.85608155 |
| 63 | PIM1 | 0.85228502 |
| 64 | PRKG2 | 0.84727111 |
| 65 | TTN | 0.79850942 |
| 66 | MAP3K13 | 0.74681163 |
| 67 | PIK3CG | 0.74522806 |
| 68 | PTK6 | 0.72240844 |
| 69 | TNK2 | 0.71958567 |
| 70 | PRKCQ | 0.71241840 |
| 71 | MST4 | 0.71202105 |
| 72 | TAOK2 | 0.71177551 |
| 73 | KSR2 | 0.69820606 |
| 74 | CAMK1D | 0.69153947 |
| 75 | CAMKK1 | 0.66980790 |
| 76 | PAK4 | 0.66780283 |
| 77 | PTK2 | 0.64347693 |
| 78 | MAP3K11 | 0.64295265 |
| 79 | ACVR1B | 0.63595341 |
| 80 | MARK2 | 0.63263540 |
| 81 | RAF1 | 0.63189352 |
| 82 | GRK7 | 0.62948268 |
| 83 | MAP3K9 | 0.59220650 |
| 84 | MAP3K2 | 0.58277875 |
| 85 | MAP2K6 | 0.57547165 |
| 86 | CDC42BPA | 0.55900735 |
| 87 | MAPKAPK2 | 0.54476421 |
| 88 | CHUK | 0.53932259 |
| 89 | MAP3K5 | 0.53269832 |
| 90 | FYN | 0.52814191 |
| 91 | GRK1 | 0.52125343 |
| 92 | SGK3 | 0.50659226 |
| 93 | PRKD2 | 0.50577102 |
| 94 | CDK9 | 0.50426355 |
| 95 | ALK | 0.49972955 |
| 96 | DMPK | 0.48787400 |
| 97 | MOS | 0.46669676 |
| 98 | MAPK7 | 0.46003868 |
| 99 | EGFR | 0.45785769 |
| 100 | RPS6KA6 | 0.45763221 |
| 101 | DAPK2 | 0.44568808 |
| 102 | FGFR1 | 0.44314975 |
| 103 | STK11 | 0.43942902 |
| 104 | MAPK4 | 0.43697658 |
| 105 | MAP3K6 | 0.43045149 |
| 106 | SIK2 | 0.42431755 |
| 107 | STK24 | 0.42392551 |
| 108 | SGK2 | 0.41822373 |
| 109 | MAP3K10 | 0.41622532 |
| 110 | KSR1 | 0.41610948 |
| 111 | PRKCD | 0.41031310 |
| 112 | CDK6 | 0.38716939 |
| 113 | TAOK3 | 0.38592949 |
| 114 | PDK1 | 0.38400868 |
| 115 | HIPK2 | 0.38022153 |
| 116 | IGF1R | 0.37449822 |
| 117 | DYRK1B | 0.36547828 |
| 118 | STK4 | 0.36214817 |
| 119 | SMG1 | 0.33571139 |
| 120 | NUAK1 | 0.33245409 |
| 121 | MAP3K7 | 0.33043468 |
| 122 | MAP3K8 | 0.32103750 |
| 123 | MELK | 0.31723831 |
| 124 | BRD4 | 0.31478037 |
| 125 | RPS6KL1 | 0.29805479 |
| 126 | RPS6KC1 | 0.29805479 |
| 127 | CAMK4 | 0.28670321 |
| 128 | EPHA3 | 0.28664699 |
| 129 | MAPK11 | 0.26427426 |
| 130 | MAPK12 | 0.26319157 |
| 131 | MAP3K1 | 0.25511231 |
| 132 | NEK9 | 0.25317324 |
| 133 | ABL1 | 0.25009614 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.40029158 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.33810204 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.98712645 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.76655330 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.63984845 |
| 6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.54308392 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.42905071 |
| 8 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.36707461 |
| 9 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 2.35185689 |
| 10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.34768194 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.22828394 |
| 12 | Measles_Homo sapiens_hsa05162 | 2.12917300 |
| 13 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.11737390 |
| 14 | Asthma_Homo sapiens_hsa05310 | 2.11379752 |
| 15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.02754619 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.88518240 |
| 17 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.87874983 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.77651807 |
| 19 | Tuberculosis_Homo sapiens_hsa05152 | 1.72532994 |
| 20 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.71594435 |
| 21 | Pertussis_Homo sapiens_hsa05133 | 1.71375997 |
| 22 | Shigellosis_Homo sapiens_hsa05131 | 1.68095032 |
| 23 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.59930195 |
| 24 | Viral myocarditis_Homo sapiens_hsa05416 | 1.56828274 |
| 25 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.55982877 |
| 26 | Hepatitis B_Homo sapiens_hsa05161 | 1.53738768 |
| 27 | Legionellosis_Homo sapiens_hsa05134 | 1.52247468 |
| 28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.50749002 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.49401947 |
| 30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.48202227 |
| 31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.44919018 |
| 32 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.44105673 |
| 33 | Other glycan degradation_Homo sapiens_hsa00511 | 1.41363931 |
| 34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.40994190 |
| 35 | Salmonella infection_Homo sapiens_hsa05132 | 1.39866736 |
| 36 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.37998113 |
| 37 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.30712501 |
| 38 | Malaria_Homo sapiens_hsa05144 | 1.28101118 |
| 39 | Influenza A_Homo sapiens_hsa05164 | 1.27701295 |
| 40 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.27240770 |
| 41 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.27185471 |
| 42 | Allograft rejection_Homo sapiens_hsa05330 | 1.24627860 |
| 43 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.20007374 |
| 44 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.18957852 |
| 45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.13716175 |
| 46 | Apoptosis_Homo sapiens_hsa04210 | 1.10687737 |
| 47 | Platelet activation_Homo sapiens_hsa04611 | 1.10632047 |
| 48 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.01864700 |
| 49 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.97234373 |
| 50 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.95799440 |
| 51 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.95578499 |
| 52 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.93547464 |
| 53 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.92256173 |
| 54 | Bladder cancer_Homo sapiens_hsa05219 | 0.88003679 |
| 55 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.86772675 |
| 56 | Hepatitis C_Homo sapiens_hsa05160 | 0.85838424 |
| 57 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.84607671 |
| 58 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.81531953 |
| 59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.81235282 |
| 60 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.80962682 |
| 61 | Phagosome_Homo sapiens_hsa04145 | 0.79459421 |
| 62 | Lysosome_Homo sapiens_hsa04142 | 0.72930271 |
| 63 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.72461070 |
| 64 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.71388414 |
| 65 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.70998678 |
| 66 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.69560046 |
| 67 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.67532911 |
| 68 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67072134 |
| 69 | Insulin resistance_Homo sapiens_hsa04931 | 0.64832703 |
| 70 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.63630072 |
| 71 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63527692 |
| 72 | Endocytosis_Homo sapiens_hsa04144 | 0.61993977 |
| 73 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.60424313 |
| 74 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.60209232 |
| 75 | HTLV-I infection_Homo sapiens_hsa05166 | 0.59760780 |
| 76 | Colorectal cancer_Homo sapiens_hsa05210 | 0.59289434 |
| 77 | Amoebiasis_Homo sapiens_hsa05146 | 0.58057684 |
| 78 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51648235 |
| 79 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.49667932 |
| 80 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.49160345 |
| 81 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48781881 |
| 82 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.48493476 |
| 83 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.48262279 |
| 84 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.48087054 |
| 85 | Endometrial cancer_Homo sapiens_hsa05213 | 0.44868866 |
| 86 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44227457 |
| 87 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.44179309 |
| 88 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.43301109 |
| 89 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.42436341 |
| 90 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.41503632 |
| 91 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.40661208 |
| 92 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38957915 |
| 93 | Adherens junction_Homo sapiens_hsa04520 | 0.38637500 |
| 94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.37953512 |
| 95 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.37630009 |
| 96 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.36288691 |
| 97 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35709408 |
| 98 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.34309972 |
| 99 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.33247586 |
| 100 | Pathways in cancer_Homo sapiens_hsa05200 | 0.32523821 |
| 101 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32307916 |
| 102 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.31457135 |
| 103 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.31443277 |
| 104 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.30040179 |
| 105 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.29942781 |
| 106 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28955351 |
| 107 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.27334986 |
| 108 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.25351945 |
| 109 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.24756698 |
| 110 | Focal adhesion_Homo sapiens_hsa04510 | 0.22702384 |
| 111 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20661971 |
| 112 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.20507546 |
| 113 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.18533043 |
| 114 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.18099728 |

